KRAS G12V

Clinical trials for KRAS G12V explained in plain language.

Never miss a new study

Get alerted when new KRAS G12V trials appear

Sign up with your email to follow new studies for KRAS G12V, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

Scientists test re-engineered immune cells to fight tough cancers

Disease control Not yet recruiting

This early-phase study is testing a new type of cell therapy called TCR-T for people with advanced solid tumors that have specific KRAS gene mutations. It aims to see if it is safe and if it can help control the cancer. The treatment involves collecting a patient's own immune cel…

Matched conditions: KRAS G12V

Phase: EARLY_PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

KRAS G12V

Get alerted when new KRAS G12V trials appear

Scientists test re-engineered immune cells to fight tough cancers